DangerousContraindicated
Desvenlafaxine blocks serotonin reuptake, while 5-HTP is converted directly into serotonin. Taking them together can push serotonin signaling into a toxic range and trigger serotonin syndrome, with agitation, tremor, sweating, diarrhea, clonus, fever, and confusion. Risk is higher with dose increases or any other serotonergic drug or substance.
Recommendation: Do not take 5-HTP while using desvenlafaxine. Stop 5-HTP and discuss a washout plan before starting desvenlafaxine. Seek urgent care for fever, muscle rigidity, clonus, severe agitation, or confusion.
DangerousContraindicated
Desvenlafaxine is an SNRI with meaningful serotonin reuptake inhibition, and L-tryptophan is converted into serotonin. Supplemental L-tryptophan can add serotonergic drive to desvenlafaxine and raise the risk of serotonin syndrome. The concern is concentrated supplementation, not normal protein intake.
Recommendation: Do not use L-tryptophan supplements while taking desvenlafaxine. Choose a non-serotonergic sleep or mood support option if needed. If you accidentally combine them, stop the supplement and monitor for agitation, tremor, sweating, diarrhea, fever, or clonus.
DangerousContraindicated
St. John's Wort has antidepressant-like serotonergic activity and is a major herb-drug interaction trigger. Combining it with desvenlafaxine can add serotonin reuptake effects and increase the risk of serotonin syndrome. St. John's Wort products vary widely in hyperforin content, making the interaction hard to predict.
Recommendation: Do not combine St. John's Wort with desvenlafaxine. Allow at least a 2-week washout after stopping St. John's Wort before starting or restarting desvenlafaxine unless your prescriber gives a different plan. Avoid other serotonergic substances during the transition.
DangerousContraindicated
Desvenlafaxine blocks serotonin and norepinephrine reuptake, and MDMA forces serotonin and norepinephrine release through the same transporter systems. Combining them can blunt desired MDMA effects while increasing risk of serotonin syndrome, hyperthermia, blood pressure spikes, arrhythmia, and seizures. Risk is greater with dehydration, overheating, redosing, or other serotonergic substances.
Recommendation: Do not use MDMA while taking desvenlafaxine. Avoid redosing if MDMA effects feel reduced; blunting does not remove toxicity risk. Seek emergency care for high fever, clonus, confusion, severe agitation, chest pain, fainting, or severe headache.